Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina
Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) in a Vulnerable Neighbourhood, Buenos Aries Argentina
1 other identifier
observational
873
1 country
1
Brief Summary
Background The study aimed to establish the seroprevalence of SARS-COV-2 in an Argentinian slum three months after the first case was reported. Methods Between June 10th and July 1st, a cross-sectional design was carried out on people over 14 years old, selected from a probabilistic sample of households. Finger prick puncture ELISA test
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2020
CompletedFirst Submitted
Initial submission to the registry
July 12, 2020
CompletedFirst Posted
Study publicly available on registry
July 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 11, 2020
CompletedDecember 17, 2020
December 1, 2020
16 days
July 12, 2020
December 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
to establish the seroprevalence of SARS-CoV-2
Prevalence of positive IgG for SARS-CoV-2
up to 20 weeks
Interventions
Serological Assay for detection of IgG for SARS-CoV-2
Eligibility Criteria
Barrio Mugica, Buenos Aires city, Argentina, This Barrio isone of the most overcrowded slums with more than 50.000 inhabitants, and almost 1500 people experiencing homelessness
You may qualify if:
- All subjects of 14 years or more who accept to be test
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Niños Ricardo Gutierrez
Buenos Aires, Buenos Aires F.D., 1425, Argentina
Related Publications (9)
Sood N, Simon P, Ebner P, Eichner D, Reynolds J, Bendavid E, Bhattacharya J. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020. JAMA. 2020 Jun 16;323(23):2425-2427. doi: 10.1001/jama.2020.8279.
PMID: 32421144BACKGROUNDPereira RJ, Nascimento GNLD, Gratao LHA, Pimenta RS. The risk of COVID-19 transmission in favelas and slums in Brazil. Public Health. 2020 Jun;183:42-43. doi: 10.1016/j.puhe.2020.04.042. Epub 2020 May 8. No abstract available.
PMID: 32422438BACKGROUNDCorburn J, Vlahov D, Mberu B, Riley L, Caiaffa WT, Rashid SF, Ko A, Patel S, Jukur S, Martinez-Herrera E, Jayasinghe S, Agarwal S, Nguendo-Yongsi B, Weru J, Ouma S, Edmundo K, Oni T, Ayad H. Slum Health: Arresting COVID-19 and Improving Well-Being in Urban Informal Settlements. J Urban Health. 2020 Jun;97(3):348-357. doi: 10.1007/s11524-020-00438-6.
PMID: 32333243BACKGROUNDMoen EL, Fricano-Kugler CJ, Luikart BW, O'Malley AJ. Analyzing Clustered Data: Why and How to Account for Multiple Observations Nested within a Study Participant? PLoS One. 2016 Jan 14;11(1):e0146721. doi: 10.1371/journal.pone.0146721. eCollection 2016.
PMID: 26766425BACKGROUNDGalbraith S, Daniel JA, Vissel B. A study of clustered data and approaches to its analysis. J Neurosci. 2010 Aug 11;30(32):10601-8. doi: 10.1523/JNEUROSCI.0362-10.2010.
PMID: 20702692BACKGROUNDAarts E, Verhage M, Veenvliet JV, Dolan CV, van der Sluis S. A solution to dependency: using multilevel analysis to accommodate nested data. Nat Neurosci. 2014 Apr;17(4):491-6. doi: 10.1038/nn.3648. Epub 2014 Mar 26.
PMID: 24671065BACKGROUNDZhang CH, Schwartz GG. Spatial Disparities in Coronavirus Incidence and Mortality in the United States: An Ecological Analysis as of May 2020. J Rural Health. 2020 Jun;36(3):433-445. doi: 10.1111/jrh.12476. Epub 2020 Jun 16.
PMID: 32543763BACKGROUNDTheel ES, Slev P, Wheeler S, Couturier MR, Wong SJ, Kadkhoda K. The Role of Antibody Testing for SARS-CoV-2: Is There One? J Clin Microbiol. 2020 Jul 23;58(8):e00797-20. doi: 10.1128/JCM.00797-20. Print 2020 Jul 23.
PMID: 32350047BACKGROUNDBuckley RM. Targeting the World's Slums as Fat Tails in the Distribution of COVID-19 Cases. J Urban Health. 2020 Jun;97(3):358-364. doi: 10.1007/s11524-020-00450-w.
PMID: 32488763BACKGROUND
Related Links
- Studies on the processes of social and urban integration in three Buenos Aires slums
- Participatory action research in health systems
- Systemic Facilitation of Collective Processes: Supporting Creativity and Participative Processes in Groups, Communities and Networks
- COVID-19 reagents
- Household and population census: villas 31 and 31 bis, City of Buenos Aires 2009
- The Color of Coronavirus: COVID-19 Deaths by Race and Ethnicity in the U.S.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alicia Mistchenko, MD PHD
Hospital de Niños Ricardo Gutierrez
- STUDY CHAIR
Vanina L Pagotto, MD MG
Hospital Italiano de Buenos Aires
- STUDY CHAIR
Silvana Figar, MD MG
Hospital Italiano de Buenos Aires
- STUDY CHAIR
Andrea Gamarnik, PHD
National Council of Scientific and Technical Research, Argentina
- STUDY CHAIR
Ana M Gomez Saldaño, MD MG
Salud Comunitaria Ministerio de Salud GCBA
- STUDY DIRECTOR
Fernan Quiroz, MD MG
Ministerio de Salud GCBA
- STUDY CHAIR
Lorena Luna, MG
Salud Comunitaria Ministerio de Salud GCBA
- STUDY CHAIR
Magdalena Wagner Manslau
Salud Comunitaria Ministerio de Salud GCBA
- STUDY CHAIR
Julieta Salto
Salud Comunitaria Ministerio de Salud GCBA
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 12, 2020
First Posted
July 15, 2020
Study Start
June 10, 2020
Primary Completion
June 26, 2020
Study Completion
December 11, 2020
Last Updated
December 17, 2020
Record last verified: 2020-12